| Dr David Grant Horsley, MD | |
|
390 N Main St, Bountiful, UT 84010-6046 | |
| (801) 294-1040 | |
| (801) 292-8369 |
| Full Name | Dr David Grant Horsley |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 33 Years |
| Location | 390 N Main St, Bountiful, Utah |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1750320552 | NPI | - | NPPES |
| 942854057086 | Medicaid | UT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 1874971205 (Utah) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Lds Hospital | Salt lake city, UT | Hospital |
| Layton Hospital | Layton, UT | Hospital |
| Intermountain Medical Center | Murray, UT | Hospital |
| Lakeview Hospital | Bountiful, UT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Intermountain Healthcare Services, Inc | 1850209420 | 3063 |
News Archive
It was a hot topic when Texas Gov. Rick Perry announced his campaign for the GOP presidential nomination. It's also been a hot topic in town hall meetings and congressional campaigns.
"Providing access to contraception for 215 million women, mainly in developing countries, would help to stabilize population growth and significantly reduce the effects of climate change," according to a report released Wednesday by the United Nations Population Fund (UNFPA), Nature News reports (Gilbert, 11/18).
ImmunoGen, Inc., a biotechnology company that develops targeted antibody-based anticancer products, today announced the start of clinical testing with SAR566658. Eight compounds are now in the clinic through ImmunoGen's product programs and those of its partners, consistent with Company expectations of as many as 12 such compounds being in the clinic by late 2011 and marked, sustained pipeline growth thereafter.
High quality trials and evidence of effective treatments for repetitive strain injury (RSI) are needed to define this controversial condition which affects millions of patients worldwide.
› Verified 1 days ago
| Entity Name | Ihc Health Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942325154 PECOS PAC ID: 1850209420 Enrollment ID: O20080610000303 |
News Archive
It was a hot topic when Texas Gov. Rick Perry announced his campaign for the GOP presidential nomination. It's also been a hot topic in town hall meetings and congressional campaigns.
"Providing access to contraception for 215 million women, mainly in developing countries, would help to stabilize population growth and significantly reduce the effects of climate change," according to a report released Wednesday by the United Nations Population Fund (UNFPA), Nature News reports (Gilbert, 11/18).
ImmunoGen, Inc., a biotechnology company that develops targeted antibody-based anticancer products, today announced the start of clinical testing with SAR566658. Eight compounds are now in the clinic through ImmunoGen's product programs and those of its partners, consistent with Company expectations of as many as 12 such compounds being in the clinic by late 2011 and marked, sustained pipeline growth thereafter.
High quality trials and evidence of effective treatments for repetitive strain injury (RSI) are needed to define this controversial condition which affects millions of patients worldwide.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr David Grant Horsley, MD Po Box 27128, Salt Lake City, UT 84127-0128 Ph: (801) 294-1040 | Dr David Grant Horsley, MD 390 N Main St, Bountiful, UT 84010-6046 Ph: (801) 294-1040 |
News Archive
It was a hot topic when Texas Gov. Rick Perry announced his campaign for the GOP presidential nomination. It's also been a hot topic in town hall meetings and congressional campaigns.
"Providing access to contraception for 215 million women, mainly in developing countries, would help to stabilize population growth and significantly reduce the effects of climate change," according to a report released Wednesday by the United Nations Population Fund (UNFPA), Nature News reports (Gilbert, 11/18).
ImmunoGen, Inc., a biotechnology company that develops targeted antibody-based anticancer products, today announced the start of clinical testing with SAR566658. Eight compounds are now in the clinic through ImmunoGen's product programs and those of its partners, consistent with Company expectations of as many as 12 such compounds being in the clinic by late 2011 and marked, sustained pipeline growth thereafter.
High quality trials and evidence of effective treatments for repetitive strain injury (RSI) are needed to define this controversial condition which affects millions of patients worldwide.
› Verified 1 days ago
Mr. Grant L. Christian, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 425 Medical Drive, Suite 118, Bountiful, UT 84010 Phone: 801-292-1422 Fax: 801-296-0436 | |
Dr. Nedda Beth Hendler, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 390 N Main St, Bountiful, UT 84010 Phone: 801-294-1044 Fax: 801-292-8369 | |
Dr. William Taylor Sadler, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 415 South Medical Drive, Suite C202, Bountiful, UT 84010 Phone: 801-295-8523 Fax: 801-295-3309 | |
Dr. Joshua Brad Oaks, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 520 Medical Dr Ste 300, Bountiful, UT 84010 Phone: 801-292-1422 Fax: 801-296-0436 | |
Val R Hansen, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 520 Medical Dr, Ste 300, Bountiful, UT 84010 Phone: 801-295-9467 | |
Bryan R. Bartholomew, DO Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 520 Medical Dr Ste 200, Bountiful, UT 84010 Phone: 801-299-7800 | |
Russell Brent Shields, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 425 N Medical Dr, Ste 108, Bountiful, UT 84010 Phone: 801-292-8444 Fax: 801-292-8476 |